Mawdsleys Pre-Wholesale to expand
Mawdsleys Pre-Wholesale to expand 13th April 2017

Coming soon – Mawdsleys’ Pre-Wholesale division to open additional site in Yorkshire

 

To make room for our growing third party logistics service at Mawdsleys Pre Wholesale (MPW), we have just completed the purchase of a brand new 18 acre site in Yorkshire (April 2017).  Work has commenced on phase one – a 150,000 sq. ft. warehouse complete with full air control systems and a state-of-the-art fit-out to comply with the latest MHRA regulations.  Significantly increasing the Mawdsley Group’s resources dedicated to pre-wholesale, the site also allows us to extend the building by a further 150,000 sq. ft. as and when required, so that we can be confident of meeting our customers’ expectations for years to come.

 

 

At MPW we have been offering bespoke and highly flexible third party storage and distribution services to the pharmaceutical industry for more than a decade. We pride ourselves on acting as an extension to our clients’ businesses, offering seamless processes and reporting to help them manage their businesses efficiently.

 

 

The expansion will give peace of mind to our current clients that we are investing in the future to support their businesses. We will also be in a very strong position to offer our services to new companies.

 

 

If you would like to speak to someone about your storage and distribution needs, please email info@mawdsleys.co.uk

 

Other latest news
https://www.mawdsleys.co.uk/news/mawdsleys-host-webinar-on-named-patient-programmes/ thumbnail image Mawdsleys Host Webinar on Named Patient Programmes

Mawdsleys is hosting a webinar to help people in the healthcare sector and pharmaceutical industry develop a deeper understanding of Named Patient Programmes. Participants of the webinar will hear how named patient programmes can be successfully implemented to treat patients who need a medicine that is not locally available to…

Read more
https://www.mawdsleys.co.uk/news/mawdsleys-and-meabco-launch-a-named-patient-supply-program-for-bp-c1/ thumbnail image Mawdsleys and Meabco launch a Named Patient Supply program for BP-C1

Mawdsleys and Meabco A/S have launched a Named Patient Supply program to allow Oncologists within the European Union (EU) to obtain access to BP-C1 on an unlicensed basis for the treatment of metastatic breast cancer and incurable pancreatic cancer.   BP-C1 is a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II)…

Read more